Trials / Unknown
UnknownNCT03832751
Human Beta-defensin 1 in Vitiligo
Estimation of Tissue Level of Human Beta-defensin 1 (HBD-1) in Vitiligo Before and After Narrowband UVB Phototherapy: a Case-control Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
There is a need to know the role of human beta defensin-1 in vitiligo pathogenesis and the probability of finding newer and effective therapy for vitiligo in the future.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | skin biopsy before and after NB-UVB phototherapy | skin biopsy before and after NB-UVB phototherapy to measure tissue human beta-defensin 1 |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2019-02-06
- Last updated
- 2019-02-06
Source: ClinicalTrials.gov record NCT03832751. Inclusion in this directory is not an endorsement.